WETS
REGN icon

Wealth Enhancement Trust Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Wealth Enhancement Trust Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.3K Buy
148
+1
+0.7% +$681 0.01% 383
2026
Q1 		$114K Buy
147
+142
+2,840% +$109K 0.01% 329
2025
Q4 		$3.86K Buy
+5
New +$3.4K ﹤0.01% 618

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Wealth Enhancement Trust Services's REGN Position: Q2 2026 in Review

Wealth Enhancement Trust Services increased its Regeneron Pharmaceuticals (REGN) stake by 0.68% in Q2 2026, buying an estimated $681 and bringing the position to 148 shares worth $92.3K. The position accounts for 0.01% of the portfolio, ranked #383.

Wealth Enhancement Trust Services first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $114K in Q1 2026. 1,001 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Wealth Enhancement Trust Services held 148 shares of Regeneron Pharmaceuticals worth $92.3K as of Q2 2026.
  • Wealth Enhancement Trust Services bought 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
  • Regeneron Pharmaceuticals made up 0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #383 holding.
  • Wealth Enhancement Trust Services first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Wealth Enhancement Trust Services's Regeneron Pharmaceuticals position peaked at $114K in Q1 2026.
  • 1,001 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.